... Serotec, Oxford, UK), anti-MHC class II monoclonal antibody (clone Tu39, mouse IgG2a; BD Pharmingen, San Diego, CA) or isotype control (clone MPC-11, mouse IgG2a; BD Pharmingen) at 10 μg/ml for 30 ... sxpressing WTMLPC for 2 weor : target ratioinistration of Whs. Although pe bcr-abl peppatients treatpeptides, theycapable of kilany clear clinimmune respon on for patienation for AMand MDS ... © Ivyspring International Publisher. All rights reserved Research Paper WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE Miwako Narita1...